Yuichiro Sakamoto Selected Research

Chemokines

4/2011	Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children.
7/2010	IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichiro Sakamoto Research Topics

Disease

24	Sepsis (Septicemia) 01/2022 - 05/2010
13	Wounds and Injuries (Trauma) 01/2021 - 12/2008
12	Disseminated Intravascular Coagulation 01/2022 - 05/2013
12	Septic Shock (Toxic Shock Syndrome) 11/2020 - 11/2006
7	Hemorrhage 05/2022 - 11/2010
5	Endotoxemia 09/2020 - 05/2007
4	Thrombosis (Thrombus) 01/2021 - 06/2010
4	Shock 06/2016 - 11/2010
3	Atrial Fibrillation 03/2021 - 01/2021
3	Infections 02/2021 - 01/2020
3	Multiple Organ Failure (MODS) 01/2021 - 06/2019
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2009
3	Hemorrhagic Shock 01/2018 - 11/2010
3	Inflammation (Inflammations) 01/2017 - 08/2011
3	Lung Injury 07/2014 - 07/2008
3	Aseptic Meningitis 08/2011 - 07/2010
3	Critical Illness (Critically Ill) 10/2010 - 01/2008
2	COVID-19 05/2022 - 01/2020
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2020 - 01/2009
2	Acute Lung Injury 01/2020 - 07/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 04/2013
2	Pulmonary Edema 07/2014 - 05/2010
2	Heart Arrest (Cardiac Arrest) 01/2013 - 11/2009
2	Fever (Fevers) 08/2011 - 04/2011
1	Collagen Diseases (Collagen Disease) 12/2021
1	Hyperglycemia 10/2021
1	Frailty 08/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2021
1	Sudden Death 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2020
1	Craniocerebral Trauma (Head Injury) 09/2020
1	Cardiac Arrhythmias (Arrythmia) 09/2020
1	Tachycardia (Tachyarrhythmias) 09/2020
1	Heart Failure 01/2020
1	Ulcer 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Fasciitis (Fascitis) 01/2020
1	Diabetes Mellitus 01/2020
1	Dextrocardia 11/2019
1	Situs Inversus 11/2019
1	Hypothermia 01/2019

Drug/Important Bio-Agent (IBA)

12	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 05/2013
10	Polymyxin B (Aerosporin)FDA LinkGeneric 11/2020 - 11/2006
5	EndotoxinsIBA 11/2020 - 05/2007
4	AntithrombinsIBA 01/2022 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 06/2019
3	CytokinesIBA 01/2017 - 07/2010
2	AnticoagulantsIBA 01/2022 - 11/2019
2	LithiumIBA 01/2021 - 01/2021
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 09/2020 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2007
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
2	Epinephrine (Adrenaline)FDA LinkGeneric 06/2016 - 01/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 04/2013 - 04/2011
2	ChemokinesIBA 04/2011 - 07/2010
2	Interleukin-17 (Interleukin 17)IBA 04/2011 - 07/2010
1	VaccinesIBA 05/2022
1	antineoplaston A10 (A 10)IBA 05/2022
1	ThrombomodulinIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 03/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2021
1	NitratesIBA 01/2021
1	Tranexamic Acid (AMCA)FDA Link 09/2020
1	Verapamil (Calan)FDA LinkGeneric 09/2020
1	LipopolysaccharidesIBA 09/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	SteroidsIBA 01/2020
1	ElementsIBA 11/2019
1	Factor XIII (Coagulation Factor XIII)IBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017

Therapy/Procedure

13	Therapeutics 01/2022 - 05/2007
10	Hemoperfusion 11/2020 - 11/2006
5	Resuscitation 01/2021 - 02/2010
3	Catheter Ablation 01/2021 - 09/2020
3	Critical Care (Surgical Intensive Care) 01/2020 - 12/2013
2	Patient Care Bundles 01/2022 - 11/2019
2	Length of Stay 08/2021 - 01/2021
2	Cardiopulmonary Resuscitation (CPR) 01/2017 - 01/2013
2	Drug Therapy (Chemotherapy) 06/2016 - 06/2014
2	Thrombectomy 06/2010 - 01/2009
1	Blood Component Removal (Apheresis) 12/2021
1	Glycemic Control 10/2021
1	Hyperbaric Oxygenation 01/2020
1	Personal Protective Equipment 01/2020
1	Catheters 11/2019
1	Electrodes (Electrode) 11/2019
1	Mechanical Ventilators (Ventilator) 01/2019
1	Central Venous Catheters 11/2018
1	Aftercare (After-Treatment) 01/2018